IP Library Granted Patent US 7,193,033
Granted Patent B2
US 7,193,033 · App. 10/311,019 · Granted Mar 20, 2007

Peptide having appetite stimulating activity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,193,033
App. No.
10/311,019
Granted
Mar 20, 2007
Kind
B2
Abstract

The present invention provides a ligand to GPR8, in particular polypeptides capable of binding to GPR8 or its amides or esters, or salts thereof, as well as DNA, encoding for such polypeptides. The ligand to GPR8 of the present invention is useful in developing a receptor-binding assay system with the use of a GPR8 expression system, for screening candidate compounds for drugs such as preventive/therapeutic agents for obesity, appetite stimulants, and prolactin production inhibitors.

Claims (18)

1. An isolated polypeptide, or an amide or ester, or a salt thereof having an amino acid sequence selected from the group consisting of:

(i) SEQ ID NO: 16,

(ii) SEQ ID NO: 16 wherein from 1 to 3 terminal amino acids are deleted

(iii) SEQ ID NO: 16 wherein from 1 to 5 terminal amino acids are added or

(iv) SEQ ID NO: 16 wherein from 1 to 3 amino acids have been substituted;

and said polypeptide has a GTPγ S binding promoting activity on cells expressing a protein comprising the amino acid sequence of SEQ ID NO:4, or its amide or ester, or a salt thereof.

2. The polypeptide or its amide or ester, or a salt thereof, according to claim 1 , which has an amino acid sequence selected from the group consisting of

(i) SEQ ID NO:16;

(ii) SEQ ID NO: 16 wherein from 1 to 3 amino acids are deleted from the carboxy terminal end,

(iii) SEQ ID NO: 16 wherein 1 to 5 amino acids are added to the carboxy terminal end, or

(iv) SEQ ID NO: 16 wherein Val at position 5 has been substituted.

3. The polypeptide or its amide or ester, or a salt thereof, according to claim 2 , which comprises the amino acid sequence of SEQ ID NO:16.

4. A composition comprising the polypeptide or its amide or ester, or a salt thereof, according to claim 1 .

5. A pharmaceutical composition comprising the polypeptide or its amide or ester, or a salt thereof, according to claim 1 .

6. An appetite stimulant comprising the polypeptide or its amide or ester, or a salt thereof, according to claim 1 .

7. A prolactin production promoting agent comprising the polypeptide or its amide or ester, or a salt thereof, according to claim 1 .

8. A kit comprising the polypeptide or its amide or ester, or a salt thereof, according to claim 1 .

9. A kit for screening according to claim 8 , further comprising a protein comprising the amino acid sequence of SEQ ID NO:4 or its amide or ester, or a salt thereof.

Assignments (3)
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2004
From: MORI, MASAAKI; SHIMOMURA, YUKIO; HARADA, MIOKO; ASAMI, TAIJI; MATSUMOTO, YOSHIO; ADACHI, YUKA; SUGO, TSUKASA; ABE, MICHIKO; GOTO, MIKA; WATANABE, TAKUYA; KITADA, CHIEKO
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 015319/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2002
From: MORI, MASAAKI; SHIMOMURA, YUKIO; HARADA, MIOKO; ASAMI, TAIJI; MATSUMOTO, YOSHIO; ADACHI, YUKA; SUGO, TSUKASA; ABE, MICHIKO
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 014530/0217 →